Glia-Like Cells from Human Mesenchymal Stem Cells Protect Neural Stem Cells in an Model of Alzheimer's Disease by Reducing NLRP-3 Inflammasome

Overview

Journal Dement Neurocogn Disord

Date 2021 Feb 8

PMID 33552214

Citations 2

Authors

Mina Hwang

Se Hyeon Song

Mi-Sook Chang

Seong-Ho Koh

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Neural stem cells (NSCs) have the ability to regenerate, proliferate, and differentiate, enabling them to play important roles in the recovery of the damaged nervous system. However, in neurodegenerative diseases such as Alzheimer's disease (AD), the NSCs are damaged as well. Glia-like cells from human mesenchymal stem cells (ghMSCs) are functionally enhanced adult stem cells. In the present study, we investigated whether ghMSCs could protect NSCs from amyloid beta (Aβ)-mediated toxicity.

Methods: Rat NSCs were obtained from E13-14 fetal rat cortices. NSCs were seeded in pre-coated plates, and the next day, cells were simultaneously treated with 20 μM Aβ and 0.4 μm pore insert well-seeded ghMSCs. After 48 hours of co-treatment, cell viability and proliferation were evaluated. After 2 hours of co-treatment, western blotting was performed to measure inflammasome-related factors, such as NOD-like receptor family pyrin domain containing 3, caspase-1, and interleukin-1β.

Results: The results showed that ghMSCs increased viability and proliferation and reduced the toxicity of NSCs injured by Aβ by reducing the NRLP3 inflammasome activation of NSCs induced by Aβ.

Conclusions: In this study, we confirmed that ghMSCs could protect NSCs in an model of AD through the regulation of inflammatory response.

Citing Articles

Brain-immune interaction mechanisms: Implications for cognitive dysfunction in psychiatric disorders.

Zhao F, Li B, Yang W, Ge T, Cui R Cell Prolif. 2022; 55(10):e13295.

PMID: 35860850 PMC: 9528770. DOI: 10.1111/cpr.13295.

Prophylactic role of Korean Red Ginseng in astrocytic mitochondrial biogenesis through HIF-1α.

Park J, Lee M, Kim M, Moon S, Kim S, Kim S J Ginseng Res. 2022; 46(3):408-417.

PMID: 35600778 PMC: 9120627. DOI: 10.1016/j.jgr.2021.07.003.

References

Oh J, Ko J, Lee H, Yu J, Choi H, Kim M . Mesenchymal stem/stromal cells inhibit the NLRP3 inflammasome by decreasing mitochondrial reactive oxygen species. Stem Cells. 2013; 32(6):1553-63. DOI: 10.1002/stem.1608. View

Hwang M, Park H, Choi H, Lee K, Lee Y, Koh S . Effects of aspirin and clopidogrel on neural stem cells. Cell Biol Toxicol. 2017; 34(3):219-232. DOI: 10.1007/s10565-017-9412-y. View

Salomone S, Caraci F, Leggio G, Fedotova J, Drago F . New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs. Br J Clin Pharmacol. 2011; 73(4):504-17. PMC: 3376428. DOI: 10.1111/j.1365-2125.2011.04134.x. View

Heneka M, Kummer M, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A . NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature. 2012; 493(7434):674-8. PMC: 3812809. DOI: 10.1038/nature11729. View

Park H, Lim M, Jung H, Lee S, Paik K, Chang M . Human mesenchymal stem cell-derived Schwann cell-like cells exhibit neurotrophic effects, via distinct growth factor production, in a model of spinal cord injury. Glia. 2010; 58(9):1118-32. DOI: 10.1002/glia.20992. View

Hofer H, Tuan R . Secreted trophic factors of mesenchymal stem cells support neurovascular and musculoskeletal therapies. Stem Cell Res Ther. 2016; 7(1):131. PMC: 5016979. DOI: 10.1186/s13287-016-0394-0. View

Halle A, Hornung V, Petzold G, Stewart C, Monks B, Reinheckel T . The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol. 2008; 9(8):857-65. PMC: 3101478. DOI: 10.1038/ni.1636. View

Haass C, Selkoe D . Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol. 2007; 8(2):101-12. DOI: 10.1038/nrm2101. View

Lee J, Jin H, Endo S, Schuchman E, Carter J, Bae J . Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses. Stem Cells. 2009; 28(2):329-43. DOI: 10.1002/stem.277. View

10.

Son J, Park J, Kim Y, Ha J, Park D, Chang M . Glia-Like Cells from Late-Passage Human MSCs Protect Against Ischemic Stroke Through IGFBP-4. Mol Neurobiol. 2019; 56(11):7617-7630. DOI: 10.1007/s12035-019-1629-8. View

11.

Park H, Lee K, Kim S, Lee J, Choi N, Lee E . Novel vaccine peptide GV1001 effectively blocks β-amyloid toxicity by mimicking the extra-telomeric functions of human telomerase reverse transcriptase. Neurobiol Aging. 2014; 35(6):1255-74. DOI: 10.1016/j.neurobiolaging.2013.12.015. View

12.

Shin J, Park H, Kim H, Oh S, Bae J, Ha H . Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models. Autophagy. 2013; 10(1):32-44. PMC: 4389879. DOI: 10.4161/auto.26508. View

13.

Kim H, Seo S, Chang J, Lee J, Kim C, Chin J . Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: A phase 1 clinical trial. Alzheimers Dement (N Y). 2018; 1(2):95-102. PMC: 5975048. DOI: 10.1016/j.trci.2015.06.007. View

14.

Studer L, Tabar V, McKay R . Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat Neurosci. 1999; 1(4):290-5. DOI: 10.1038/1105. View

15.

Prinz M, Priller J, Sisodia S, Ransohoff R . Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat Neurosci. 2011; 14(10):1227-35. DOI: 10.1038/nn.2923. View

16.

Currle D, Hu J, Kolski-Andreaco A, Monuki E . Culture of mouse neural stem cell precursors. J Vis Exp. 2008; (2):152. PMC: 2532938. DOI: 10.3791/152. View

17.

Basha Paspala S, Murthy T, Mahaboob V, Habeeb M . Pluripotent stem cells - a review of the current status in neural regeneration. Neurol India. 2011; 59(4):558-65. DOI: 10.4103/0028-3886.84338. View

18.

Nakano M, Kubota K, Kobayashi E, Chikenji T, Saito Y, Konari N . Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an Alzheimer's disease model by increasing the expression of microRNA-146a in hippocampus. Sci Rep. 2020; 10(1):10772. PMC: 7330036. DOI: 10.1038/s41598-020-67460-1. View

19.

Chojnacki A, Weiss S . Production of neurons, astrocytes and oligodendrocytes from mammalian CNS stem cells. Nat Protoc. 2008; 3(6):935-40. DOI: 10.1038/nprot.2008.55. View

20.

Pittenger M, Discher D, Peault B, Phinney D, Hare J, Caplan A . Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med. 2019; 4:22. PMC: 6889290. DOI: 10.1038/s41536-019-0083-6. View